Inhibition of HIV-1 protease and RNase H of HIV-1 reverse transcriptase activities by long chain phenols from the sarcotestas of Ginkgo biloba

Planta Medica

Volumn 74, Issue 5, 2008, Pages 532-534

  Ji, Suk Lee ^a   Hattori, Masao ^b   Kim, Jinwoong ^a  

^a Seoul National University   (South Korea)

^b UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Alkylsalicylic acid; Bilobol; Ginkgo biloba; Ginkgoaceae; HIV 1 protease; Long chain phenol; RNase H of HIV 1 reverse transcriptase

Indexed keywords

ACETYLPEPSTATIN; BILOBOL C; CARDANOL C; ILLIMAQUINONE; NEVIRAPINE; PROTEINASE; PROTEINASE INHIBITOR; RIBONUCLEASE H; RNA DIRECTED DNA POLYMERASE; SALICYLIC ACID;

ARTICLE; DRUG INHIBITION; DRUG ISOLATION; DRUG STRUCTURE; ENZYME ACTIVITY; GINKGO BILOBA; IC 50; ISOMERISM;

GINKGO BILOBA; HIV PROTEASE; HIV PROTEASE INHIBITORS; HIV REVERSE TRANSCRIPTASE; PHENOLS; REVERSE TRANSCRIPTASE INHIBITORS; RIBONUCLEASE H, HUMAN IMMUNODEFICIENCY VIRUS;

GINKGO BILOBA; GINKGOACEAE; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 43249113647     PISSN: 00320943     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1074497     Document Type: Article

References (14)

1. De Clercq E. Toward improved anti-HIV chemotherapy: therapeutic strategies for intervention with HIV infections. J Med Chem 1995; 38: 2491-527
2. Fauci AS. Multifactorial nature of human immunodeficiency virus disease; implications for therapy. Science 1993; 262: 1011-8
3. Loya S, Hizi A. The interaction of illimaquinone, a selective inhibitor of the RNase H activity, with the reverse transcriptase of human immunodeficiency and murine leukemia retroviruses. J Biol Chem 1993; 268: 9323-8
4. Starnes MC, Cheng YC. Human immunodeficiency virus reverse transcriptase-associated RNase H activity. J Biol Chem 1989; 264: 7073-7
5. Lee JS, Cho YS, Park EJ, Kim J, Oh WK, Lee HS et al. Phospholipase Cγ1 inhibitory principles from the sarcotestas of Ginkgo biloba. J Nat Prod 1998; 61: 867-71
6. Itokawa H, Totsuka N, Nakahara K, Takeya K, Lepoittevin JP, Asakawa Y. Antitumor principles from Ginkgo biloba L. Chem Pharm Bull 1987; 35: 3016-20
7. Claeys M, Van den Heuvel H, Claereboudt J, Corthout J, Pieters L, Vlietinck AJ. Determination of the double bond position in long-chain 6-alkenyl salicylic acids by collisional activation. Biol Mass Spectrom 1993; 22: 647-53
8. Min BS, Miyashiro H, Hattori M. Inhibitory effects of quinones on RNase H activity associated with HIV-1 reverse transcriptase. Phytother Res 2002; 16: S57-62
9. Min BS, Nakamura N, Miyashiro H, Kim YH, Hattori M. Inhibition of human immunodeficiency virus type-1 reverse transcriptase and ribonuclease H activities by constituents of Juglans mandshuria. Chem Pharm Bull 2000; 48: 194-200
10. Koch E, Jaggy H, Chatterjee SS. Evidences for immunotoxic effects of crude Ginkgo biloba L. leaf extracts using popliteal lymph node assay in the mouse. Int J Immunopharmacol 2000; 22: 229-36
11. Ahlemeyer B, Selke D, Schaper C, Klumpp S, Krieglstein J. Ginkgolic acids induce neuronal death and activate protein phosphatase type-2C. Eur J Pharmacol 2001; 430: 1-7
12. Bjorn MH. The sensitizing capacity of ginkgolic acids in guinea pigs. Am J Contact Dermatitis 1998; 9: 146-8
13. Ma C, Nakamura N, Miyashiro H, Hattori M, Shimotohno K. Inhibitory effects of constituents from Cynomorium songaricum and related triterpene derivatives on HIV-1 protease. Chem Pharm Bull 1999; 47: 141-5
14. Ahn MJ, Yoon KD, Min SY, Lee JS, Kim JH, Kim TG et al. Inhibition of HIV-1 reverse transcriptase and protease by phlorotannins from the brown alga Ecklonia cava. Biol Pharm Bull 2004; 27: 544-7